Showing results (401-410 of 658) with videos related to
Sort By:
Pageof 66
Neuro-Oncology|April 7, 2019
REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesisAnantha L Marisetty, Li Lu, Bethany L Veo, et al.Neuro-Oncology Advances|January 7, 2026
Combined inhibition of lysine-specific demethylase 1 and kinase signaling as a preclinical treatment strategy in glioblastomaLea M Stitzlein, Deokhwa Nam, Faith A Hernandez, et al.Acta Neuropathologica Communications|January 19, 2024
The genomic alterations in glioblastoma influence the levels of CSF metabolitesDaniel H Wang, Yoko Fujita, Antonio Dono, et al.Journal of Cellular Physiology|May 22, 2024
Noninvasive therapy of brain cancer using a unique systemic delivery methodology with a cancer terminator virusPraveen Bhoopathi, Padmanabhan Mannangatti, Anjan K Pradhan, et al.Journal of Neurosurgery|April 10, 2026
Reevaluating routine imaging: clinical utility of postoperative CT after stereotactic brain biopsyChristina Abi Faraj, Nelson S Moss, Cheuk Hong Leung, et al.Neuro-Oncology|May 12, 2020
Adult immuno-oncology: using past failures to inform the futureMaryam Rahman, W Gregory Sawyer, Scott Lindhorst, et al.JAMA Ophthalmology|December 27, 2019
Vascular Changes in the Retina and Choroid of Patients With EPAS1 Gain-of-Function Mutation SyndromePauline M Dmitriev, Herui Wang, Jared S Rosenblum, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02Roshan S Prabhu, Minhee Won, Edward G Shaw, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastomaTerri S Armstrong, Jeffrey S Wefel, Meihua Wang, et al.Neuro-Oncology Advances|May 29, 2026
Inhibition of chemokine CXCL12 modulates the tumor microenvironment in glioblastoma and potentiates immune checkpoint inhibitor efficacy in a tissue-specific mannerChen Makranz, Caitlin Huguely, Meili Zhang, et al.Pageof 66